Author
TransPharm Preclinical Solutions
Post
Fecal Transplants Treat C. difficile Infections
CDI often occurs after long-term treatment with broad-spectrum antibiotics, which can drastically alter the normal bowel flora and decrease healthy…
Read more
Post
Phage Therapy Against Super Bugs
Superbugs, or multi-drug resistant (MDR) bacteria, are bacteria that cannot be killed using two or more antibiotics. As antimicrobial resistance…
Read more
Post
Preclinical Research Study Timeline
Our experienced and knowledgeable staff will help you navigate the preclinical period of your research project from beginning to end. Check out the…
Read more
Post
Spring 2018 Newsletter
Although TransPharm is best known for our animal models of infectious disease, we have recently had more requests for our in vitro services. We'd…
Read more
Post
Zolav®: A New Antibiotic for the Treatment of Acne
Zolav®: A New Antibiotic for the Treatment of Acne
Boulos and Cooper Pharmaceuticals
Read more
Post
Winter 2018 Newsletter
The Super Bowl may be over, but our team is always training to compete against Super Bugs! Super bugs, or multi-drug resistant bacteria, are bacteria…
Read more
Post
Entrepreneurial plunge pays off for former Pfizer employees
Dan and Samantha Ross had just built a 4,000-square-foot log cabin for themselves in Jackson County when their employer, the drug giant Pfizer Inc…
Read more
Post
Handling deadly diseases, Michigan company earns $12 million in first 10 years
TransPharm Preclinical Solutions, a life sciences company in rural Napoleon Township, celebrated its 10-year anniversary on January 2, 2018. With…
Read more
Post
Fall 2017 Newsletter
TransPharm has added a new animal model of induced chronic osteomyelitis (bone infection). Osteomyelitis results in pain, loss of mobility, and…
Read more
Post
Summer 2017 Newsletter
We are searching for TransPharm’s Next Top Model! Our team has been focused on validating new murine models of infectious disease, including…
Read more